Department of Neurosurgery, University of Innsbruck, Austria.
AJNR Am J Neuroradiol. 2011 Sep;32(8):1386-91. doi: 10.3174/ajnr.A2507. Epub 2011 Jun 16.
Thromboembolic events after aneurysm coiling are common, but the optimal algorithm for emboli prevention remains unclear. MESs correlate with the occurrence of impending ischemic events and may be used for management guidance. This study reports the use of MES monitoring with regard to aneurysm characteristics and coiling technique after a specific anticoagulation protocol.
We analyzed 123 consecutive, elective endovascular procedures. Patients received intraprocedural and continuous heparin if feasible. Demographic data, aneurysm size, type of intervention/complication, medication, imaging, and clinical outcome were analyzed. MES monitoring was performed in all patients both immediately after as well as >12 hours after the procedure.
Heparinization within the first 12 hours was associated with lower numbers of MESs early after coiling (3.4 versus 18.8 MESs/hr). When on heparin, larger aneurysm size, stent-assisted procedures, or incomplete occlusion did not lead to a significant increase in MESs. If the initial MES count on heparin was >10 MESs/hr, it was always safe to discontinue heparin. Inability to initiate early, continuous heparinization was associated with new neurologic deficits. Additional administration of antiplatelet agents showed lower MES counts initially, but the difference was not significant.
MES monitoring is a powerful adjunct to monitor efficacy of treatment algorithms for emboli prevention after coiling. In our series, early heparinization was associated with a lower incidence of MESs. This is of particular importance in larger aneurysms, stent-assisted procedures, and incomplete occlusions, in which the thromboembolic risk is greatest early on and antiplatelet treatment alone may not suffice.
动脉瘤弹簧圈栓塞术后发生血栓栓塞事件较为常见,但预防栓塞的最佳方案仍不明确。微栓子信号(MESs)与即将发生的缺血性事件相关,可用于指导治疗管理。本研究报告了在特定抗凝方案后,根据动脉瘤特征和弹簧圈技术使用 MES 监测的情况。
我们分析了 123 例连续的择期血管内治疗病例。如果可行,患者在术中及持续接受肝素治疗。分析人口统计学数据、动脉瘤大小、干预/并发症类型、药物治疗、影像学和临床结果。所有患者均在术毕即刻及术后>12 小时进行 MES 监测。
前 12 小时内肝素化与栓塞后早期 MES 数量较低(3.4 比 18.8 MESs/hr)相关。如果使用肝素,较大的动脉瘤大小、支架辅助治疗或不完全闭塞不会导致 MES 明显增加。如果肝素初始 MES 计数>10 MESs/hr,则可安全停用肝素。无法早期开始持续肝素化与新的神经功能缺损有关。早期加用抗血小板药物会导致初始 MES 计数较低,但差异无统计学意义。
MES 监测是一种强大的辅助手段,可监测弹簧圈栓塞后预防栓塞治疗方案的效果。在我们的系列研究中,早期肝素化与 MES 发生率较低相关。这在较大的动脉瘤、支架辅助治疗和不完全闭塞中尤为重要,因为这些情况下早期血栓栓塞风险最大,单纯抗血小板治疗可能不够。